Introducing the world's most advanced stem cell technology, originating from Japan's pioneering techniques and combining Japanese craftsmanship with cutting-edge technology. XOSOME provides precise and targeted solutions for various health issues, leveraging professional knowledge and high-end technology to precisely target the root causes of patients' ailments through mesenchymal stem cells, which possess automatic tracking capabilities.
The XOSOME logo embodies the brand's commitment to accuracy and efficacy. The crosshairs represent the product's ability to precisely target and provide effective treatment plans for patients, hitting the mark with a single blow.
As a pioneer in advanced therapies, XOSOME is dedicated to scientific research and evidence-based practice, contributing to the advancement of regenerative medicine through rigorous research and clinical validation.
Japan's First
XOSOME formed a technology transfer partnership with BMS, a subsidiary of Japan's Otsuka Pharmaceutical Co., Ltd., the first Japanese government-certified stem cell processing center. They gradually introduced and improved professional knowledge and technology in Hong Kong.
Asia's First International Highest Standard
Established in 2019 at the Hong Kong Science Park, XOSOME is committed to realizing the vision of health and longevity through stem cell technology. It has become the first stem cell therapy manufacturer in Asia to achieve the international highest standard - the Pharmaceutical Inspection Co-operation Scheme (PIC/S).
